English
简体中文
Total: £ 56.28
Published Date: 2026-03-16 | Pages: 119 | Tables: 119 | Service & Software
The global Biolayer Interferometry (BLI) market was valued at US$ 391 million in 2025 and is anticipated to reach US$ 724 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
The Biolayer Interferometry (BLI) market has been expanding rapidly due to its increasing use in a wide range of applications such as drug discovery, biotechnology, diagnostics, and life sciences research. BLI is a powerful, label-free, and real-time optical biosensing technique that is widely used for studying molecular interactions. Here are the most prominent market trends for BLI:
BLI is becoming an essential tool in drug discovery and biopharmaceutical development. The technique is crucial for assessing the interactions of small molecules, antibodies, peptides, and other therapeutics with biological targets. BLI is particularly useful in the screening of drug candidates, kinetic analysis, and the characterization of biologics like monoclonal antibodies and biosimilars.
With increased emphasis on biologics, biomolecular interactions, and antibody-drug conjugates (ADCs), the demand for BLI instruments is surging in pharmaceutical research labs, contract research organizations (CROs), and biotechnology companies.
One of the key advantages of BLI is its ability to monitor biomolecular interactions in real-time without the need for labels like fluorescence or radioactivity. This is especially important for applications in kinetic studies, where changes in molecular binding or dissociation are observed in real time. The technology’s label-free nature also makes it a more cost-effective and sustainable option compared to traditional assays.
Real-time monitoring allows for high-throughput analysis, which is essential for large-scale drug screening campaigns and biomarker discovery.
The BLI market is benefiting from its integration with high-throughput screening (HTS) platforms. The combination of label-free detection and the ability to screen large numbers of samples in a short time is making BLI a popular choice in drug development and compound screening. This integration is especially useful for accelerating the early stages of drug discovery.
Many manufacturers are developing BLI systems that can be easily integrated into existing HTS workflows, improving efficiency and throughput while providing high-quality interaction data.
This report delivers a comprehensive overview of the global Biolayer Interferometry (BLI) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biolayer Interferometry (BLI). The Biolayer Interferometry (BLI) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biolayer Interferometry (BLI) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biolayer Interferometry (BLI) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ichor Life Sciences, Inc
Creative BioMart
GenScript
ROCKLAND IMMUNOCHEMICALS, INC
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
Biocult
KMD Bioscience Co., Ltd
Segment by Type
Affinity and Kinetic Analysis
Drug and Antibody Screening
Drug and Antibody Discovery
Protein Quantification
Others
Segment by Application
Pharmaceutical Industry
Diagnostics
Biotechnology
Scientific Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Biolayer Interferometry (BLI) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Affinity and Kinetic Analysis
1.2.3 Drug and Antibody Screening
1.2.4 Drug and Antibody Discovery
1.2.5 Protein Quantification
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biolayer Interferometry (BLI) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Diagnostics
1.3.4 Biotechnology
1.3.5 Scientific Research
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biolayer Interferometry (BLI) Market Perspective (2021–2032)
2.2 Global Biolayer Interferometry (BLI) Growth Trends by Region
2.2.1 Global Biolayer Interferometry (BLI) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Biolayer Interferometry (BLI) Historic Market Size by Region (2021–2026)
2.2.3 Biolayer Interferometry (BLI) Forecasted Market Size by Region (2027–2032)
2.3 Biolayer Interferometry (BLI) Market Dynamics
2.3.1 Biolayer Interferometry (BLI) Industry Trends
2.3.2 Biolayer Interferometry (BLI) Market Drivers
2.3.3 Biolayer Interferometry (BLI) Market Challenges
2.3.4 Biolayer Interferometry (BLI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biolayer Interferometry (BLI) Players by Revenue
3.1.1 Global Top Biolayer Interferometry (BLI) Players by Revenue (2021–2026)
3.1.2 Global Biolayer Interferometry (BLI) Revenue Market Share by Players (2021–2026)
3.2 Global Top Biolayer Interferometry (BLI) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Biolayer Interferometry (BLI) Revenue
3.4 Global Biolayer Interferometry (BLI) Market Concentration Ratio
3.4.1 Global Biolayer Interferometry (BLI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biolayer Interferometry (BLI) Revenue in 2025
3.5 Global Key Players of Biolayer Interferometry (BLI) Head Offices and Areas Served
3.6 Global Key Players of Biolayer Interferometry (BLI), Products and Applications
3.7 Global Key Players of Biolayer Interferometry (BLI), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Biolayer Interferometry (BLI) Breakdown Data by Type
4.1 Global Biolayer Interferometry (BLI) Historic Market Size by Type (2021–2026)
4.2 Global Biolayer Interferometry (BLI) Forecasted Market Size by Type (2027–2032)
5 Biolayer Interferometry (BLI) Breakdown Data by Application
5.1 Global Biolayer Interferometry (BLI) Historic Market Size by Application (2021–2026)
5.2 Global Biolayer Interferometry (BLI) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Biolayer Interferometry (BLI) Market Size (2021–2032)
6.2 North America Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Biolayer Interferometry (BLI) Market Size by Country (2021–2026)
6.4 North America Biolayer Interferometry (BLI) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biolayer Interferometry (BLI) Market Size (2021–2032)
7.2 Europe Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Biolayer Interferometry (BLI) Market Size by Country (2021–2026)
7.4 Europe Biolayer Interferometry (BLI) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Biolayer Interferometry (BLI) Market Size (2021–2032)
8.2 Asia-Pacific Biolayer Interferometry (BLI) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (2021–2026)
8.4 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Biolayer Interferometry (BLI) Market Size (2021–2032)
9.2 Latin America Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Biolayer Interferometry (BLI) Market Size by Country (2021–2026)
9.4 Latin America Biolayer Interferometry (BLI) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biolayer Interferometry (BLI) Market Size (2021–2032)
10.2 Middle East & Africa Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021–2026)
10.4 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ichor Life Sciences, Inc
11.1.1 Ichor Life Sciences, Inc Company Details
11.1.2 Ichor Life Sciences, Inc Business Overview
11.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Introduction
11.1.4 Ichor Life Sciences, Inc Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.1.5 Ichor Life Sciences, Inc Recent Development
11.2 Creative BioMart
11.2.1 Creative BioMart Company Details
11.2.2 Creative BioMart Business Overview
11.2.3 Creative BioMart Biolayer Interferometry (BLI) Introduction
11.2.4 Creative BioMart Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.2.5 Creative BioMart Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Biolayer Interferometry (BLI) Introduction
11.3.4 GenScript Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.3.5 GenScript Recent Development
11.4 ROCKLAND IMMUNOCHEMICALS, INC
11.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Details
11.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview
11.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Introduction
11.4.4 ROCKLAND IMMUNOCHEMICALS, INC Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Development
11.5 BPS Bioscience, Inc
11.5.1 BPS Bioscience, Inc Company Details
11.5.2 BPS Bioscience, Inc Business Overview
11.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Introduction
11.5.4 BPS Bioscience, Inc Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.5.5 BPS Bioscience, Inc Recent Development
11.6 Creative Proteomics
11.6.1 Creative Proteomics Company Details
11.6.2 Creative Proteomics Business Overview
11.6.3 Creative Proteomics Biolayer Interferometry (BLI) Introduction
11.6.4 Creative Proteomics Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.6.5 Creative Proteomics Recent Development
11.7 Creative Biostructure
11.7.1 Creative Biostructure Company Details
11.7.2 Creative Biostructure Business Overview
11.7.3 Creative Biostructure Biolayer Interferometry (BLI) Introduction
11.7.4 Creative Biostructure Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.7.5 Creative Biostructure Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Biolayer Interferometry (BLI) Introduction
11.8.4 Profacgen Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.8.5 Profacgen Recent Development
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Details
11.9.2 Creative Biolabs Business Overview
11.9.3 Creative Biolabs Biolayer Interferometry (BLI) Introduction
11.9.4 Creative Biolabs Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.9.5 Creative Biolabs Recent Development
11.10 Biocult
11.10.1 Biocult Company Details
11.10.2 Biocult Business Overview
11.10.3 Biocult Biolayer Interferometry (BLI) Introduction
11.10.4 Biocult Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.10.5 Biocult Recent Development
11.11 KMD Bioscience Co., Ltd
11.11.1 KMD Bioscience Co., Ltd Company Details
11.11.2 KMD Bioscience Co., Ltd Business Overview
11.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Introduction
11.11.4 KMD Bioscience Co., Ltd Revenue in Biolayer Interferometry (BLI) Business (2021–2026)
11.11.5 KMD Bioscience Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Affinity and Kinetic Analysis
Table 3. Key Players of Drug and Antibody Screening
Table 4. Key Players of Drug and Antibody Discovery
Table 5. Key Players of Protein Quantification
Table 6. Key Players of Others
Table 7. Global Biolayer Interferometry (BLI) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Biolayer Interferometry (BLI) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Biolayer Interferometry (BLI) Market Size by Region (US$ Million), 2021–2026
Table 10. Global Biolayer Interferometry (BLI) Market Share by Region (2021–2026)
Table 11. Global Biolayer Interferometry (BLI) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Biolayer Interferometry (BLI) Market Share by Region (2027–2032)
Table 13. Biolayer Interferometry (BLI) Market Trends
Table 14. Biolayer Interferometry (BLI) Market Drivers
Table 15. Biolayer Interferometry (BLI) Market Challenges
Table 16. Biolayer Interferometry (BLI) Market Restraints
Table 17. Global Biolayer Interferometry (BLI) Revenue by Players (US$ Million), 2021–2026
Table 18. Global Biolayer Interferometry (BLI) Market Share by Players (2021–2026)
Table 19. Global Top Biolayer Interferometry (BLI) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biolayer Interferometry (BLI) Revenue, 2025
Table 20. Ranking of Global Top Biolayer Interferometry (BLI) Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Biolayer Interferometry (BLI) Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Biolayer Interferometry (BLI), Headquarters and Area Served
Table 23. Global Key Players of Biolayer Interferometry (BLI), Products and Applications
Table 24. Global Key Players of Biolayer Interferometry (BLI), Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Biolayer Interferometry (BLI) Market Size by Type (US$ Million), 2021–2026
Table 27. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2021–2026)
Table 28. Global Biolayer Interferometry (BLI) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2027–2032)
Table 30. Global Biolayer Interferometry (BLI) Market Size by Application (US$ Million), 2021–2026
Table 31. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021–2026)
Table 32. Global Biolayer Interferometry (BLI) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2027–2032)
Table 34. North America Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2021–2026
Table 36. North America Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Biolayer Interferometry (BLI) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (US$ Million), 2027–2032
Table 49. Ichor Life Sciences, Inc Company Details
Table 50. Ichor Life Sciences, Inc Business Overview
Table 51. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product
Table 52. Ichor Life Sciences, Inc Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 53. Ichor Life Sciences, Inc Recent Development
Table 54. Creative BioMart Company Details
Table 55. Creative BioMart Business Overview
Table 56. Creative BioMart Biolayer Interferometry (BLI) Product
Table 57. Creative BioMart Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 58. Creative BioMart Recent Development
Table 59. GenScript Company Details
Table 60. GenScript Business Overview
Table 61. GenScript Biolayer Interferometry (BLI) Product
Table 62. GenScript Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 63. GenScript Recent Development
Table 64. ROCKLAND IMMUNOCHEMICALS, INC Company Details
Table 65. ROCKLAND IMMUNOCHEMICALS, INC Business Overview
Table 66. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product
Table 67. ROCKLAND IMMUNOCHEMICALS, INC Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 68. ROCKLAND IMMUNOCHEMICALS, INC Recent Development
Table 69. BPS Bioscience, Inc Company Details
Table 70. BPS Bioscience, Inc Business Overview
Table 71. BPS Bioscience, Inc Biolayer Interferometry (BLI) Product
Table 72. BPS Bioscience, Inc Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 73. BPS Bioscience, Inc Recent Development
Table 74. Creative Proteomics Company Details
Table 75. Creative Proteomics Business Overview
Table 76. Creative Proteomics Biolayer Interferometry (BLI) Product
Table 77. Creative Proteomics Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 78. Creative Proteomics Recent Development
Table 79. Creative Biostructure Company Details
Table 80. Creative Biostructure Business Overview
Table 81. Creative Biostructure Biolayer Interferometry (BLI) Product
Table 82. Creative Biostructure Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 83. Creative Biostructure Recent Development
Table 84. Profacgen Company Details
Table 85. Profacgen Business Overview
Table 86. Profacgen Biolayer Interferometry (BLI) Product
Table 87. Profacgen Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 88. Profacgen Recent Development
Table 89. Creative Biolabs Company Details
Table 90. Creative Biolabs Business Overview
Table 91. Creative Biolabs Biolayer Interferometry (BLI) Product
Table 92. Creative Biolabs Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 93. Creative Biolabs Recent Development
Table 94. Biocult Company Details
Table 95. Biocult Business Overview
Table 96. Biocult Biolayer Interferometry (BLI) Product
Table 97. Biocult Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 98. Biocult Recent Development
Table 99. KMD Bioscience Co., Ltd Company Details
Table 100. KMD Bioscience Co., Ltd Business Overview
Table 101. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product
Table 102. KMD Bioscience Co., Ltd Revenue in Biolayer Interferometry (BLI) Business (US$ Million), 2021–2026
Table 103. KMD Bioscience Co., Ltd Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Biolayer Interferometry (BLI) Picture
Figure 2. Global Biolayer Interferometry (BLI) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Biolayer Interferometry (BLI) Market Share by Type: 2025 vs 2032
Figure 4. Affinity and Kinetic Analysis Features
Figure 5. Drug and Antibody Screening Features
Figure 6. Drug and Antibody Discovery Features
Figure 7. Protein Quantification Features
Figure 8. Others Features
Figure 9. Global Biolayer Interferometry (BLI) Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Biolayer Interferometry (BLI) Market Share by Application: 2025 vs 2032
Figure 11. Pharmaceutical Industry Case Studies
Figure 12. Diagnostics Case Studies
Figure 13. Biotechnology Case Studies
Figure 14. Scientific Research Case Studies
Figure 15. Others Case Studies
Figure 16. Biolayer Interferometry (BLI) Report Years Considered
Figure 17. Global Biolayer Interferometry (BLI) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 18. Global Biolayer Interferometry (BLI) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Biolayer Interferometry (BLI) Market Share by Region: 2025 vs 2032
Figure 20. Global Biolayer Interferometry (BLI) Market Share by Players in 2025
Figure 21. Global Biolayer Interferometry (BLI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Biolayer Interferometry (BLI) Revenue in 2025
Figure 23. North America Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. North America Biolayer Interferometry (BLI) Market Share by Country (2021–2032)
Figure 25. United States Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Canada Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Biolayer Interferometry (BLI) Market Share by Country (2021–2032)
Figure 29. Germany Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. France Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. U.K. Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Italy Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Russia Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Ireland Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Biolayer Interferometry (BLI) Market Share by Region (2021–2032)
Figure 37. China Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Japan Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. South Korea Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Southeast Asia Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. India Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Australia & New Zealand Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Biolayer Interferometry (BLI) Market Share by Country (2021–2032)
Figure 45. Mexico Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Brazil Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country (2021–2032)
Figure 49. Israel Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Saudi Arabia Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. UAE Biolayer Interferometry (BLI) Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Ichor Life Sciences, Inc Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 53. Creative BioMart Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 54. GenScript Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 55. ROCKLAND IMMUNOCHEMICALS, INC Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 56. BPS Bioscience, Inc Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 57. Creative Proteomics Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 58. Creative Biostructure Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 59. Profacgen Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 60. Creative Biolabs Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 61. Biocult Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 62. KMD Bioscience Co., Ltd Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
